Federated Hermes Inc. Sells 4,228 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Federated Hermes Inc. has reduced its stake in Prestige Consumer Healthcare Inc. by 31.5%, selling 4,228 shares and holding 9,190 shares valued at approximately $790,000 as of the latest SEC filing.
• Several institutional investors increased their holdings in Prestige Consumer Healthcare, with Geode Capital Management growing its stake by 1.7% to over $105 million.
• Currently, Wall Street analysts have a consensus rating of "Hold" for Prestige Consumer Healthcare stock, with a target price of $93.33, reflecting recent upgrades and downgrades in analyst coverage.

Federated Hermes Inc. reduced its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 31.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,190 shares of the company's stock after selling 4,228 shares during the period. Federated Hermes Inc.'s holdings in Prestige Consumer Healthcare were worth $790,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of PBH. Geode Capital Management LLC grew its holdings in Prestige Consumer Healthcare by 1.7% in the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock worth $105,342,000 after purchasing an additional 21,951 shares during the period. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in Prestige Consumer Healthcare in the fourth quarter worth about $84,932,000. Invesco Ltd. grew its holdings in shares of Prestige Consumer Healthcare by 2.4% during the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after buying an additional 24,392 shares during the last quarter. Congress Asset Management Co. grew its holdings in shares of Prestige Consumer Healthcare by 9.1% during the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after buying an additional 82,838 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Prestige Consumer Healthcare by 10.9% during the fourth quarter. Northern Trust Corp now owns 813,076 shares of the company's stock valued at $63,493,000 after buying an additional 80,055 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Canaccord Genuity Group lowered their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research report on Friday. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Performance

PBH traded down $2.00 during trading on Friday, hitting $65.61. The company's stock had a trading volume of 785,601 shares, compared to its average volume of 440,546. The company has a quick ratio of 2.82, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a one year low of $63.78 and a one year high of $90.04. The firm has a market cap of $3.24 billion, a PE ratio of 15.40, a P/E/G ratio of 1.97 and a beta of 0.43. The business's 50 day simple moving average is $79.26 and its 200-day simple moving average is $82.06.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same quarter in the previous year, the business posted $0.90 earnings per share. The firm's revenue was down 6.6% on a year-over-year basis. As a group, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.